-
February 1, 2012
CORRECTION: Seed therapy for prostate cancer may zap fertility
NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.
-
February 1, 2012
Seed therapy for prostate cancer may zap fertility
NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.
-
December 29, 2011
Milk intake in teens tied to later prostate cancer
NEW YORK (Reuters Health) - Older Icelandic men who remember chugging a lot of milk in their teens are three times as likely to be diagnosed with advanced prostate cancer as more-moderate milk drinkers, researchers have found.
-
December 29, 2011
Statins tied to lower risk of fatal prostate cancer
NEW YORK (Reuters Health) - In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.
-
December 7, 2011
Some men can delay prostate cancer treatment-panel
CHICAGO (Reuters) - Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.
-
December 6, 2011
Prostate cancer hormonal therapy cuts deaths: report
NEW YORK (Reuters Health) - For men with aggressive prostate cancer, hormone-targeted therapy cuts the overall risk of death, according to a new review of past studies.
-
December 1, 2011
Hormonal prostate cancer therapy tied to blood clots
NEW YORK (Reuters Health) - Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, a large U.S. study suggests.
-
October 11, 2011
Vitamin E tied to higher risk of prostate cancer
NEW YORK (Reuters Health) - Men taking daily vitamin E were more likely to get prostate cancer than those not taking the dietary supplement in a new study of close to 35,000 North Americans.
-
October 7, 2011
PSA test for prostate cancer not recommended-US panel
CHICAGO (Reuters) - A U.S. government-backed panel recommended against routine prostate cancer screening on Friday because widespread screening for the disease causes more harm than good.
-
September 26, 2011
Roche bone drug eases pain in prostate cancer trial
STOCKHOLM (Reuters) - Roche's bone strengthening drug Boniva is as good for pain relief as single dose radiotherapy in patients whose prostate cancer has spread to their bones, according to data from a late-stage trial released on Sunday.
-
September 7, 2011
J&J's prostate cancer drug approved in EU
LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.
-
September 6, 2011
Zimbabwe's Mugabe has prostate cancer: WikiLeaks
JOHANNESBURG (Reuters) - Zimbabwean President Robert Mugabe has prostate cancer that has spread to other organs and was urged by his physician to step down in 2008, according to a U.S. diplomatic cable released by WikiLeaks.
-
August 26, 2011
Doctors misuse scans in prostate cancer: study
NEW YORK (Reuters Health) - Too many men with low- or medium-risk prostate cancer get CTs and bone scans that aren't recommended for them, suggests a new study.
-
June 21, 2011
Smoking makes prostate cancer deadlier: study
CHICAGO (Reuters) - Smoking increases the risk that men who develop prostate cancer will die from their disease, U.S. researchers said on Tuesday.
-
June 9, 2011
Prostate drugs raise risk of prostate cancer: FDA
WASHINGTON (Reuters) - A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday.
-
June 7, 2011
Safe to skip radiation for prostate cancer?
NEW YORK (Reuters Health) - A review of recent studies comparing different radiation treatments for prostate cancer reveals no clear picture of what works best for the majority of men with the disease.
-
June 6, 2011
Exelixis drug slows prostate cancer spread in trial
CHICAGO (Reuters) - Exelixis Inc's cabozantinib experimental drug shrank bone malignancies from prostate cancer in 76 percent of patients, interim results from a midstage trial show.
-
June 1, 2011
Cholesterol drugs tied to lower prostate cancer risk
NEW YORK (Reuters Health) - Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study.
-
May 13, 2011
Rising prostate cancer rate seen in U.S. servicemen
NEW YORK (Reuters Health) - The rate of prostate cancer among active-duty U.S. Air Force members has been several times higher in recent years than it was 20 years ago, a new study finds.
-
May 5, 2011
CORRECTION: Supplements don't prevent prostate cancer: study
NEW YORK (Reuters Health) - A new study deflates hopes that certain nutritional supplements could stave off prostate cancer, the second most common cancer in men.
-
April 13, 2011
More evidence for waiting to treat prostate cancer
NEW YORK (Reuters Health) - For older men with low-risk prostate cancer, a new study adds to evidence that closely watching the tumor instead of immediately treating it may be a reasonable option.
-
March 29, 2011
Too many old men get prostate cancer tests: study
NEW YORK (Reuters Health) - Many men in their 80s get regular blood tests for prostate cancer even though there's no evidence the tests will benefit them, according to a new study.
-
March 17, 2011
Costlier prostate cancer treatments gain popularity
NEW YORK (Reuters Health) - Newer technologies for treating prostate cancer have surged in popularity in the last decade -- and they have come with a hefty price tag, according to a report published this week.
-
March 2, 2011
Often okay to skip prostate cancer treatment: study
NEW YORK (Reuters Health) - Many men with less aggressive forms of prostate cancer choose to forgo treatment, and a new study provides more evidence that this option is safe for older men, even those with riskier forms of the disease.
-
February 24, 2011
PSA spikes are poor predictors of prostate cancer
CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S. researchers said on Thursday.
-
February 18, 2011
Exelixis drug shows promise in prostate cancer
LOS ANGELES (Reuters) - Exelixis Inc's experimental cancer drug cabozantinib has been shown in a mid-stage trial to completely or partially clear up bone lesions from prostate cancer in 85 percent of patients, according to research presented on Thursday.
-
February 17, 2011
Exelixis drug shows promise in prostate cancer
LOS ANGELES (Reuters) - Exelixis Inc's experimental cancer drug cabozantinib has been shown in a mid-stage trial to completely or partially clear up bone lesions from prostate cancer in 85 percent of patients, according to research presented on Thursday.
-
February 16, 2011
Early balding linked to risk of prostate cancer
LONDON (Reuters) - A study showing that men who start to go bald at 20 may be more likely to develop prostate cancer in later life suggests they might benefit from early screening or preventative therapy, scientists said on Tuesday.
-
February 10, 2011
Gene test may cut need for prostate cancer surgery
LONDON (Reuters) - A genetic pattern could predict how aggressive prostate cancer is, potentially saving many men with less threatening tumors from undergoing unnecessary and life-changing surgery, scientists said on Wednesday.
-
December 27, 2010
Prostate cancer treatment may be tied to cataracts
NEW YORK (Reuters Health) - Older men who opt for hormone-blocking therapy to treat prostate cancer might be slightly raising their risk of developing cataracts, hints new research.
-
December 7, 2010
Older men get less effective prostate cancer care
NEW YORK (Reuters Health) - Old age is no hindrance to benefiting from prostate cancer surgery and radiation therapy, according to a new U.S. study that shows men over 75 often get less effective treatment than their younger peers.
-
November 30, 2010
Prostate cancer: Watching and waiting may be best
CHICAGO (Reuters) - Older men with low-risk prostate cancer may be better off getting regular check-ups that rushing to get surgery or radiation, researchers using a computer model suggested on Tuesday.
-
November 29, 2010
Issues seen with drugs to curb prostate cancer-FDA
WASHINGTON, (Reuters) - U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc < and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.
-
November 12, 2010
Prostate Cancer Treatment May Up Colon Cancer Risk
NEW YORK (Reuters Health) - Men who opt for hormone-blocking therapy to treat prostate cancer may be increasing their risk of developing colon cancer, hints a study published this week in the Journal of the National Cancer Institute.
-
November 1, 2010
Prostate cancer screening may help healthy men only
NEW YORK (Reuters Health) - Screening men for prostate cancer makes sense only if they are generally healthy, U.S. researchers said on Monday.
-
October 25, 2010
Aspirin may boost prostate cancer treatment: study
WASHINGTON (Reuters) - Cheap, easy-to-take aspirin tablets may help men being treated for prostate cancer live longer, U.S. researchers reported on Monday.
-
October 20, 2010
US FDA orders new warnings on prostate cancer drugs
WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday.
-
October 14, 2010
Protein urine test may signal prostate cancer
LONDON (Reuters) - A protein in urine could be a strong indicator of prostate cancer risk, according to British scientists, who say their findings could one day be developed into a quick and simple test for the disease.
-
October 11, 2010
J&J drug offers hope in advanced prostate cancer
MILAN, (Reuters) - Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.
-
October 7, 2010
Fish-filled diet may cut prostate cancer mortality
NEW YORK (Reuters Health) - Eating lots of fish may not protect men from developing prostate cancer, but it could reduce their risk of dying from the disease, a new review of the medical literature suggests.
-
September 16, 2010
GTx-prostate cancer drug causes medical castration
LOS ANGELES (Reuters) - Higher doses of an experimental prostate cancer drug being developed by GTx Inc were shown in an early-stage trial to induce temporary medical castration in healthy volunteers, the company said on Tuesday.
-
September 1, 2010
No risk seen from delaying prostate cancer surgery
NEW YORK (Reuters Health) - Adding to evidence that men with early prostate cancer can safely put off surgery, a new study finds that patients who delayed surgery by over a year had similar outcomes as those who opted for immediate treatment.
-
August 25, 2010
Even when prostate cancer returns, most survive
NEW YORK (Reuters Health) - Men who show signs that their disease has returned after prostate cancer treatment are still more likely to die of other causes, a new study in US veterans shows.
-
August 2, 2010
Gene variants in Japanese prostate cancer patients
HONG KONG (Reuters) - A large study in Japan into possible genetic causes for prostate cancer has uncovered five new gene variants that have never been seen in previous studies in Caucasians, researchers said on Monday.
-
July 26, 2010
Low-risk prostate cancer treated aggressively
CHICAGO (Reuters) - Many men with low-risk prostate cancer get aggressive treatment, increasing the risk of serious side effects, U.S. researchers said on Monday.
-
July 21, 2010
No link seen between coffee, prostate cancer risk
NEW YORK (Reuters Health) - Men who enjoy their morning cup of coffee can drink a little easier. A new research review finds that java lovers appear no more likely to develop prostate cancer than other men.
-
January 27, 2010
Genetic factors key to prostate cancer death risk
LONDON (Reuters) - A combination of three genetic abnormalities has a dramatic impact on how long prostate cancer patients are likely to live, researchers said on Wednesday, and gene tests could help doctors decide on the best treatments.
-
January 26, 2010
Alternative prostate cancer vaccine shows promise
WASHINGTON (Reuters) - A prostate cancer vaccine that uses relatives of smallpox virus helped patients with advanced and otherwise untreatable cancer live longer, U.S. researchers reported on Monday.
-
January 11, 2010
Gene may pinpoint most aggressive prostate cancer
WASHINGTON (Reuters) - Researchers have found a genetic mutation that helps predict which men will have aggressive prostate cancer and said it might help doctors choose who needs treatment and who does not.
-
December 8, 2009
Exercise can benefit men with prostate cancer
NEW YORK (Reuters Health) - As little as 15 minutes of physical activity a day can substantially cut death rates in men with prostate cancer, new research hints.